Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference
29 December 2022 - 08:00AM
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial
Biology Company®, today announced that it will be participating in
the 41st Annual J.P. Morgan Healthcare Conference.
Brian McKelligon, CEO, is scheduled to present on Wednesday,
January 11th, 2023 at 9:45 a.m. PT.
A live and archived webcast of the event will be available on
the “Investors” section of the Akoya website at
https://investors.akoyabio.com/.
About Akoya BiosciencesAs The Spatial Biology
Company®, Akoya Biosciences’ mission is to bring context to the
world of biology and human health through the power of spatial
phenotyping. The company offers comprehensive single-cell imaging
solutions that allow researchers to phenotype cells with spatial
context and visualize how they organize and interact to influence
disease progression and response to therapy. Akoya offers a full
continuum of spatial phenotyping solutions to serve the diverse
needs of researchers across discovery, translational and clinical
research via its key platforms: PhenoCycler™, PhenoImager™ Fusion
and PhenoImager HT. To learn more about Akoya,
visit www.akoyabio.com.
Investor Contact:Priyam ShahSr. Director,
Investor RelationsAkoya Biosciences, Inc.investors@akoyabio.com
Media Contact:Christine Quern(617)
650-8497media@akoyabio.com
Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
From Mar 2023 to Mar 2024